Dr Reddys Laboratories Ltd Share Price Today - Live Blog for February 28, 2026

The share price of Dr Reddys Laboratories Ltd plunged by -2.50%, leaving investors concerned. At this moment, the stock can be acquired at 1286.30, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd shares saw a -2.50% decrease, reaching a current market price of 1286.30. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.4500, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -2.50%, a situation worth noting. At present, the stock is trading at 1286.30. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.4500, while the industry PE ratio is 32.4990.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -2.50% in its share price, and it currently trades at 1286.30 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -2.50%, presenting both challenges and opportunities for investors. As of now, it's trading at 1286.30, and market participants are assessing the implications. The stock has a PE ratio of 19.4500, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

With a -2.50% decrease, Dr Reddys Laboratories Ltd's share price is currently at 1286.30. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.4500, while the industry PE is 32.4990.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -2.50% in its share price, and it currently trades at 1286.30 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -2.50%, a situation worth noting. At present, the stock is trading at 1286.30. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.4500, while the industry PE ratio is 32.4990.

Dr Reddys Laboratories Ltd's share price has fallen by -2.50%, presenting both challenges and opportunities for investors. As of now, it's trading at 1286.30, and market participants are assessing the implications. The stock has a PE ratio of 19.4500, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -2.50% in its share price, and it currently trades at 1286.30 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -2.50% in its share price, and it currently trades at 1286.30 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -2.50%, a situation worth noting. At present, the stock is trading at 1286.30. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.4500, while the industry PE ratio is 32.4990.